未登录

C

C. Christiansen

Zealand University Hospital

H指数:43

被引数:6,261

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Investigations of HLA-F and HLA-G 3′UTR Polymorphisms in Preeclampsia and Fetal Growth Restriction Indicate a Possible Role of HLA-F-HLA-G Haplotypes and Diplotypes

对子痫前期和胎儿生长受限中HLA-F和HLA-G 3′UTR多态性的研究，提示HLA-F-HLA-G单倍型和基因分型可能存在一定作用。

IF4.1

2025-07-020

OA

Biaryl Anion Radical Formation by Potassium Metal Reduction of Aryl Isocyanates and Triaryl Isocyanurates

JOURNAL OF ORGANIC CHEMISTRY

IF3.6

2024-10-130

OAAI

GIP Receptor Antagonism Eliminates Paradoxical Growth Hormone Secretion in Some Patients With Acromegaly

GIP受体拮抗作用可消除某些肢端肥大症患者的反常生长激素分泌

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2024-08-221

OA

Jensen, Mette H.; Gasbjerg, Laerke S.; Skov-Jeppesen, Kirsa; Jacobsen, Jens C. B.; Poulsen, Steen S.; Zhou, Cuiqi; Jakubauskaite, Ruta; Poulsen, Frantz R.; Bonde, Christian; Albarazi, Mahmoud; Halle, Bo; Christiansen, Charlotte B.; Sanni, Samra J.; Byberg, Sarah; Hoe, Bjorn; Holst, Jens J.; Dela, Flemming; Rasmussen, Aase K.; Knop, Filip K.; Arlien-Soborg, Mai C.; Melmed, Shlomo; Jorgensen, Jens Otto L.; Andersen, Marianne S.; Hartmann, Bolette; Klose, Marianne C.; Feldt-Rasmussen, Ulla; Sparre-Ulrich, Alexander H.; Rosenkilde, Mette M.

The Severity of DSS-Induced Colitis Is Independent of the SCFA-FFAR2/3-GLP-1 Pathway Despite SCFAs Inducing GLP-1 Secretion via FFAR2/3

尽管scfa通过SCFA-FFAR2/3诱导GLP-1分泌，但DSS诱导的结肠炎的严重程度与FFAR2/3-GLP-1途径无关。

IF3.7

2024-07-200

OAAI

Effects of Exogenous GIP and GLP-2 on Bone Turnover in Individuals With Type 2 Diabetes

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2024-01-133

OA

Colonic Lactulose Fermentation Has No Impact on Glucagon-like Peptide-1 and Peptide-YY Secretion in Healthy Young Men

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2021-09-118

OA

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with short bowel syndrome and colon in continuity: an open-label pilot study

BMJ OPEN GASTROENTEROLOGY

IF2.9

2021-05-118

OAAI

The Gut Peptide Neurotensin Does Not Reduce Appetite and Food Intake in Healthy Young Men

IF7.5

2020-06-010

PRE

Bile acids drive colonic secretion of glucagon-like-peptide 1 and peptide-YY in rodents

胆汁酸驱动啮齿动物胰高血糖素样肽1和肽YY的结肠分泌

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

IF3.3

2019-05-0149

OAAI

Neuromedin U Does Not Act as a Decretin in Rats

CELL METABOLISM

IF30.9

2019-03-0110

OAAI

Insulin Secretion Depends on Intra- islet Glucagon Signaling

IF6.9

2018-10-01264

OAAI

Volume of ropivacaine 0.2% and common peroneal nerve block duration: a randomised, double-blind cohort trial in healthy volunteers

IF6.9

2018-09-0518

OAAI

The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

IF3.3

2018-07-01289

OAAI

TOTAL JOINT REPLACEMENT (TJR) AS CLINICAL ENDPOINT IN OA; PREVALENCE AND INCIDENCE RATES OF TJRS FROM THE PROSPECTIVE EPIDEMIOLOGIC RISK FACTOR (PERF I) STUDY

OSTEOARTHRITIS AND CARTILAGE

IF9

2018-04-011

OAAI

GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release

BIOCHEMICAL PHARMACOLOGY

IF5.6

2017-05-0165

OAAI

Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP Secretion

肠道中的甜味受体激活对葡萄糖刺激的GLP-1和GIP分泌的重要性有限

IF5

2017-04-2233

OAAI

Glucagon-like Peptide 1 Receptor Signaling in Acinar Cells Causes Growth-Dependent Release of Pancreatic Enzymes

IF6.9

2016-12-0127

OAAI

GLP1-and GIP-producing cells rarely overlap and differ by bombesin receptor-2 expression and responsiveness

JOURNAL OF ENDOCRINOLOGY

IF3.9

2015-10-1943

OAAI

Separation of healthy and early osteoarthritis by automatic quantification of cartilage homogeneity

OSTEOARTHRITIS AND CARTILAGE

IF9

2007-10-0158

OA

Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects

European Journal of Clinical Nutrition

IF3.3

1999-10-1950

PREAI